Drug Profile


Alternative Names: PFT - alpha

Latest Information Update: 03 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Quark Biotech; University of Illinois at Chicago
  • Class Antineoplastics; Benzene derivatives; Benzothiazoles; Chemoprotectants; Small molecules
  • Mechanism of Action Tumour suppressor protein p53 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Cerebral ischaemia; Radiation injuries

Most Recent Events

  • 03 Apr 2007 Discontinued - Preclinical for Chemotherapy induced damage (Prevention)/Chemoprotection in USA (unspecified route)
  • 03 Apr 2007 Discontinued - Preclinical for Cerebral ischaemia in USA (unspecified route)
  • 03 Apr 2007 Discontinued - Preclinical for Radiation injuries (Prevention)/Radioprotection in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top